Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
University of Rochester
1121
mi
from
Rochester, NY
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
University of Rochester
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
958
mi
from
Charlotte, NC
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
958
mi
from
Charlotte, NC
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Cleveland, Inc.
904
mi
from
Beachwood, OH
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Cleveland, Inc.
904
mi
from
Beachwood, OH
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Northwest, PC
1383
mi
from
Portland, OR
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Northwest, PC
1383
mi
from
Portland, OR
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Casey Eye Institute
1383
mi
from
Portland, OR
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Casey Eye Institute
1383
mi
from
Portland, OR
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvania Scheie Eye Institute
1225
mi
from
Philadelphia, PA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania Scheie Eye Institute
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Southeastern Retina Associates, P.C.
777
mi
from
Knoxville, TN
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Southeastern Retina Associates, P.C.
777
mi
from
Knoxville, TN
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Southwest Retina Specialists
286
mi
from
Amarillo, TX
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Southwest Retina Specialists
286
mi
from
Amarillo, TX
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Austin Retina Associates
515
mi
from
Austin, TX
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Austin Retina Associates
515
mi
from
Austin, TX
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Research Center
515
mi
from
Austin, TX
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Research Center
515
mi
from
Austin, TX
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina and Vitreous of Texas
569
mi
from
Houston, TX
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina and Vitreous of Texas
569
mi
from
Houston, TX
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
572
mi
from
Houston, TX
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
572
mi
from
Houston, TX
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Texas Retina Associates
374
mi
from
Lubbock, TX
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Texas Retina Associates
374
mi
from
Lubbock, TX
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Valley Retina Institute, P.A.
797
mi
from
McAllen, TX
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Valley Retina Institute, P.A.
797
mi
from
McAllen, TX
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of San Antonio
576
mi
from
San Antonio, TX
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of San Antonio
576
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Utah
779
mi
from
Salt Lake City, UT
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Utah
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Virginia Retina Center
1098
mi
from
Leesburg, VA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Virginia Retina Center
1098
mi
from
Leesburg, VA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Institute of Virginia
1106
mi
from
Richmond, VA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Institute of Virginia
1106
mi
from
Richmond, VA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
University of Washington Medical Center
1410
mi
from
Seattle, WA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
University of Washington Medical Center
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service
575
mi
from
Madison, WI
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service
575
mi
from
Madison, WI
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Atlantis Eye Care
1162
mi
from
Huntington Beach, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Atlantis Eye Care
1162
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Northern California Retina Vitreous Associates
1325
mi
from
Mountain View, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Northern California Retina Vitreous Associates
1325
mi
from
Mountain View, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Group of New England
1386
mi
from
New London, CT
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Group of New England
1386
mi
from
New London, CT
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Thomas Eye Group
796
mi
from
Sandy Springs, GA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Thomas Eye Group
796
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Medical Associates Clinic, PC
500
mi
from
Dubuque, IA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Medical Associates Clinic, PC
500
mi
from
Dubuque, IA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
The Retina Institute
418
mi
from
Saint Louis, MO
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
The Retina Institute
418
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
899
mi
from
Cleveland, OH
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
899
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Baylor Eye Physicians and Surgeons
569
mi
from
Houston, TX
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Baylor Eye Physicians and Surgeons
569
mi
from
Houston, TX
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Spokane Eye Clinic
1201
mi
from
Spokane, WA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Spokane Eye Clinic
1201
mi
from
Spokane, WA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Associates, PA
190
mi
from
Shawnee Mission, KA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Associates, PA
190
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
Iluvien Registry Safety Study
An Open Label, Registry Study of the Safety of Iluvien® 190 Micrograms Intravitreal Implant in Applicator
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
801
mi
from
Atlanta, GA
Iluvien Registry Safety Study
An Open Label, Registry Study of the Safety of Iluvien® 190 Micrograms Intravitreal Implant in Applicator
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa
Modulating Ocular/Retinal Blood Flow and Visual Function in Retinitis Pigmentosa
Status: Enrolling
Updated:  12/31/1969
Nova Southeastern University; College of Optometry
1303
mi
from
Fort Lauderdale, FL
Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa
Modulating Ocular/Retinal Blood Flow and Visual Function in Retinitis Pigmentosa
Status: Enrolling
Updated: 12/31/1969
Nova Southeastern University; College of Optometry
1303
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of Arizona and Retinal Research Institute
850
mi
from
Phoenix, AZ
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of Arizona and Retinal Research Institute
850
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Associated Retina Consultants
853
mi
from
Phoenix, AZ
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Associated Retina Consultants
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego, Jacobs Retina Center, Shiley Eye Center
mi
from
La Jolla, CA
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego, Jacobs Retina Center, Shiley Eye Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Northern California Retina Vitreous Associates
1325
mi
from
Mountain View, CA
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Northern California Retina Vitreous Associates
1325
mi
from
Mountain View, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Southern Colorado
386
mi
from
Colorado Springs, CO
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Southern Colorado
386
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
"National Ophthalmic Research Institute Retina Consultants of Southwest Florida"
mi
from
Fort Myers, FL
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
"National Ophthalmic Research Institute Retina Consultants of Southwest Florida"
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Specialty Institute
789
mi
from
Pensacola, FL
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Specialty Institute
789
mi
from
Pensacola, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Associates of Florida
1114
mi
from
Saint Petersburg, FL
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Associates of Florida
1114
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Southern Vitreoretinal Associates, PL
mi
from
Tallahassee, FL
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Southern Vitreoretinal Associates, PL
mi
from
Tallahassee, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Center for Retina and Macular Disease
1148
mi
from
Winter Haven, FL
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Center for Retina and Macular Disease
1148
mi
from
Winter Haven, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Georgia Retina, P.C.
805
mi
from
Decatur, GA
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Georgia Retina, P.C.
805
mi
from
Decatur, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Raj K. Maturi, MD
644
mi
from
Indianapolis, IN
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Raj K. Maturi, MD
644
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Western New York
1124
mi
from
Rochester, NY
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Western New York
1124
mi
from
Rochester, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Charlotte Eye, Ear, Nose & Throat Associates
958
mi
from
Charlotte, NC
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Charlotte Eye, Ear, Nose & Throat Associates
958
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Oregon Retina, LLP
1382
mi
from
Eugene, OR
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Oregon Retina, LLP
1382
mi
from
Eugene, OR
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Casey Eye Institute, Oregon Health & Science University
1384
mi
from
Portland, OR
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Casey Eye Institute, Oregon Health & Science University
1384
mi
from
Portland, OR
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Mid Atlantic Retina, Wills Eye Retina Surgeons
mi
from
Philadelphia, PA
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Mid Atlantic Retina, Wills Eye Retina Surgeons
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Research Institute of Texas, LLC
388
mi
from
Abilene, TX
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Research Institute of Texas, LLC
388
mi
from
Abilene, TX
Click here to add this to my saved trials